NR1D1 and cancer: However, in the cancer cells, REV-ERBα knockdown or its antagonist did not consistently up-regulate the CR regulator genes and key lipid metabolism genes (SI Appendix, Fig. S2D), suggesting that REV-ERBα has lost its canonical CR regulator function in cancer cells.